Bdx stock price forecast short-term traders watching the BDX

Short-term traders watching the BDX stock price forecast highlight a bullish 50-day moving average crossover. Momentum indicators suggest increased buying interest in anticipation of upcoming FDA approvals for new product lines. Becton Dickinson's US$256 share price signals that it might be 21% undervalued "This transaction is an important milestone for BD, as it enhances our strategic focus as a leading medical technology company. BD is committed to unlocking long-term value through continued investment in our strong innovation pipeline, and operational and commercial excellence that will drive durable and profitable growth. BD will also receive a cash distribution of approximately $4 billion, which enhances our capital allocation framework, including a commitment to use at least half of the cash proceeds to repurchase shares, with the remaining balance allocated to debt repayment." Current BDX stock price forecast shows moderate upside potential, backed by stronger-than-expected consumable sales in the healthcare market. Technical charts suggest a key resistance level near $242, which could trigger short-term momentum if breached.